Schizoaffective
12
2
2
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
8.3%
1 terminated out of 12 trials
88.9%
+2.4% vs benchmark
8%
1 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (12)
Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness
Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia
Is Cognitive Training an Option?
Treatment of Refractory Schizophrenia With Riluzole
Safety and Tolerability of Varenicline in Schizophrenia (SATOVA)
Evaluation of QTc Interval by Continuous Holter ECG Recording in Antipsychotic Drug-treated Patients With Schizophrenia
Influence of Acupuncture on Emotional Measures and Quality of Sleep Among Schizophrenia Patients
Psychiatric Advance Directives for Improved Mental Health Care
An Open Trial of Cysteamine Treatment in Schizophrenia
The Consta Club: A Demonstration Project for Setting up a Consta Club in a Community Mental Health Center
Cognitive Remediation and Social Skills Training in Schizophrenia
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?